J.D. Pipkin

665 total citations
34 papers, 529 citations indexed

About

J.D. Pipkin is a scholar working on Pharmaceutical Science, Molecular Biology and Materials Chemistry. According to data from OpenAlex, J.D. Pipkin has authored 34 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmaceutical Science, 8 papers in Molecular Biology and 7 papers in Materials Chemistry. Recurrent topics in J.D. Pipkin's work include Drug Solubulity and Delivery Systems (10 papers), Crystallization and Solubility Studies (5 papers) and Advanced Drug Delivery Systems (5 papers). J.D. Pipkin is often cited by papers focused on Drug Solubulity and Delivery Systems (10 papers), Crystallization and Solubility Studies (5 papers) and Advanced Drug Delivery Systems (5 papers). J.D. Pipkin collaborates with scholars based in United States, Japan and Spain. J.D. Pipkin's co-authors include Gerald S. Rork, A.J. Repta, Arto Urtti, V.J. Stella, Toshiaki Sendo, Kaneto Uekama, Ángel Piñeiro, Fumitoshi Hirayama, Rebeca García‐Fandiño and Miriana Kfoury and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Blood.

In The Last Decade

J.D. Pipkin

34 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.D. Pipkin United States	16	209	175	68	67	58	34	529
Varun Khurana United States	16	211 1.0×	332 1.9×	112 1.6×	37 0.6×	50 0.9×	22	893
Nagesh Bandi United States	12	355 1.7×	186 1.1×	71 1.0×	97 1.4×	27 0.5×	13	798
Shin-ichi Yasueda Japan	9	112 0.5×	84 0.5×	102 1.5×	23 0.3×	44 0.8×	15	363
Chien‐Ming Hsieh Taiwan	16	96 0.5×	185 1.1×	19 0.3×	37 0.6×	58 1.0×	38	583
Kalyani Mondal India	16	32 0.2×	421 2.4×	45 0.7×	64 1.0×	29 0.5×	32	749
Somnath Singh United States	17	242 1.2×	199 1.1×	21 0.3×	29 0.4×	57 1.0×	34	713
Vincent H.L. Lee United States	16	301 1.4×	210 1.2×	247 3.6×	14 0.2×	37 0.6×	27	743
Hitoshi Ozawa Japan	13	37 0.2×	126 0.7×	58 0.9×	62 0.9×	47 0.8×	22	362
Viral Kansara United States	18	125 0.6×	391 2.2×	48 0.7×	30 0.4×	53 0.9×	30	864
Rishikesh M. Kulkarni United States	8	502 2.4×	224 1.3×	35 0.5×	110 1.6×	64 1.1×	10	965

Countries citing papers authored by J.D. Pipkin

Since Specialization

Citations

This map shows the geographic impact of J.D. Pipkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.D. Pipkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.D. Pipkin more than expected).

Fields of papers citing papers by J.D. Pipkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.D. Pipkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.D. Pipkin. The network helps show where J.D. Pipkin may publish in the future.

Co-authorship network of co-authors of J.D. Pipkin

This figure shows the co-authorship network connecting the top 25 collaborators of J.D. Pipkin. A scholar is included among the top collaborators of J.D. Pipkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.D. Pipkin. J.D. Pipkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

O’Connor, Matthew S., J.D. Pipkin, Milo Malanga, et al.. (2025). A comprehensive nomenclature system for cyclodextrins. Carbohydrate Polymers. 360. 123600–123600. 1 indexed citations

Legrand, François‐Xavier, et al.. (2022). Huge solubility increase of poorly water-soluble pharmaceuticals by sulfobutylether-β-cyclodextrin complexation in a low-melting mixture. Environmental Chemistry Letters. 20(3). 1561–1568. 15 indexed citations

Piñeiro, Ángel, et al.. (2021). Aggregation versus inclusion complexes to solubilize drugs with cyclodextrins. A case study using sulphobutylether-β-cyclodextrins and remdesivir. Journal of Molecular Liquids. 343. 117588–117588. 16 indexed citations

Zagami, Roberto, Domenico Franco, J.D. Pipkin, et al.. (2020). Sulfobutylether-β-cyclodextrin/5,10,15,20-tetrakis(1-methylpyridinium-4-yl)porphine nanoassemblies with sustained antimicrobial phototherapeutic action. International Journal of Pharmaceutics. 585. 119487–119487. 21 indexed citations

Kfoury, Miriana, et al.. (2017). Captisol®: an efficient carrier and solubilizing agent for essential oils and their components. Flavour and Fragrance Journal. 32(5). 340–346. 17 indexed citations

Anraku, Makoto, et al.. (2015). Slow-release of famotidine from tablets consisting of chitosan/sulfobutyl ether β-cyclodextrin composites. International Journal of Pharmaceutics. 487(1-2). 142–147. 18 indexed citations

Aljitawi, Omar S., Siddhartha Ganguly, Sunil Abhyankar, et al.. (2014). Phase IIa cross-over study of propylene glycol-free melphalan (LGD-353) and alkeran in multiple myeloma autologous transplantation. Bone Marrow Transplantation. 49(8). 1042–1045. 19 indexed citations

Anraku, Makoto, Daisuke Iohara, Kaneto Uekama, et al.. (2014). Formation of Elastic Gels from Deacetylated Chitin Nanofibers Reinforced with Sulfobutyl Ether β-Cyclodextrin. Chemistry Letters. 44(3). 285–287. 8 indexed citations

Aljitawi, Omar S., Anna Ludlow, Siddhartha Ganguly, et al.. (2012). Propylene Glycol-Free Melphalan Induces Higher Remission Rates in Multiple Myeloma Patients Undergoing Autologous Transplantation. Blood. 120(21). 4551–4551. 1 indexed citations

10.

Aljitawi, Omar S., Siddhartha Ganguly, Sunil Abhyankar, et al.. (2011). Interim PK analysis results of a phase IIa, open-label, randomized, pharmacokinetic comparative, cross-over study of melphalan HCl for injection (propylene glycol-free) and alkeran for injection for myeloablative conditioning in multiple myeloma patients undergoing autologous transplantation.. Journal of Clinical Oncology. 29(15_suppl). 6571–6571. 1 indexed citations

11.

Motoyama, Keiichi, Fumitoshi Hirayama, Naomi Ono, et al.. (2011). Effect of sulfobutyl ether-β-cyclodextrin on bioavailability of insulin glargine and blood glucose level after subcutaneous injection to rats. International Journal of Pharmaceutics. 419(1-2). 71–76. 18 indexed citations

12.

Aljitawi, Omar S., et al.. (2011). Phase IIa, Open-Label, Randomized, Pharmacokinetic Comparative, Cross-Over Study of Melphalan HCl for Injection (Propylene Glycol-Free) and Alkeran for Injection for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation. Blood. 118(21). 4512–4512. 1 indexed citations

13.

Samra, Hardeep S., Feng He, Akhilesh Bhambhani, et al.. (2010). The Effects of Substituted Cyclodextrins on the Colloidal and Conformational Stability of Selected Proteins. Journal of Pharmaceutical Sciences. 99(6). 2800–2818. 35 indexed citations

14.

Salapatek, A., et al.. (2009). Novel Combination Product Captisol-Enabled® Budesonide + Azelastine HCl Provides Fast, Long-lasting Relief of Allergic Rhinitis Symptoms (Total Nasal Symptom Score (TNSS) and Individual Nasal Symptoms Scores (NSS)) in Ragweed Allergic Patients Studied in an Environmental Exposure Chamber (EEC) Model. Journal of Allergy and Clinical Immunology. 123(2). S130–S130. 1 indexed citations

15.

Ranadive, Sunanda A., et al.. (1995). Formation, isolation and identification of oligomers of aztreonam. European Journal of Pharmaceutical Sciences. 3(5). 281–291. 6 indexed citations

16.

Sutton, Steven C., Edward L. LeCluyse, Karen Engle, J.D. Pipkin, & Joseph A. Fix. (1993). Enhanced Bioavailability of Cefoxitin Using Palmitoylcarnitine. II. Use of Directly Compressed Tablet Formulations in the Rat and Dog. Pharmaceutical Research. 10(10). 1516–1520. 14 indexed citations

17.

Cheng, Haiyung, Steven C. Sutton, J.D. Pipkin, et al.. (1993). Evaluation of Sustained/Controlled-Release Dosage Forms of 3-Hydroxy-3-methylglutaryl–Coenzyme A (HMG-CoA) Reductase Inhibitors in Dogs and Humans. Pharmaceutical Research. 10(11). 1683–1687. 27 indexed citations

18.

Urtti, Arto, J.D. Pipkin, Gerald S. Rork, & A.J. Repta. (1990). Controlled drug delivery devices for experimental ocular studies with timolol 1. In vitro release studies. International Journal of Pharmaceutics. 61(3). 235–240. 36 indexed citations

19.

Urtti, Arto, Toshiaki Sendo, J.D. Pipkin, Gerald S. Rork, & A.J. Repta. (1988). Application Site Dependent Ocular Absorption of Timolol. Journal of Ocular Pharmacology and Therapeutics. 4(4). 335–343. 13 indexed citations

20.

Pipkin, J.D. & V.J. Stella. (1983). Phenindione solubility in mixed organic solvents: analysis of the role of specific hydrogen and non-hydrogen bonding interactions. International Journal of Pharmaceutics. 14(2-3). 263–277. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact